Literature DB >> 20943754

Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice.

José Córdoba-Chacón1, Manuel D Gahete, Justo P Castaño, Rhonda D Kineman, Raul M Luque.   

Abstract

Somatostatin (SST) inhibits growth hormone (GH) secretion and regulates multiple processes by signaling through its receptors sst1-5. Differential expression of SST/ssts may contribute to sex-specific GH pattern and fasting-induced GH rise. To further delineate the tissue-specific roles of SST and sst1-5 in these processes, their expression patterns were evaluated in hypothalamus, pituitary, and stomach of male and female mice under fed/fasted conditions in the presence (wild type) or absence (SST-knockout) of endogenous SST. Under fed conditions, hypothalamic/stomach SST/ssts expression did not differ between sexes, whereas male pituitary expressed more SST and sst2A/2B/3/5A/5TMD2/5TMD1 and less sst1, and male pituitary cell cultures were more responsive to SST inhibitory actions on GH release compared with females. This suggests that local pituitary SST/ssts can contribute to the sexually dimorphic pattern of GH release. Fasting (48 h) reduced stomach sst2A/B and hypothalamic SST/sst2A expression in both sexes, whereas it caused a generalized downregulation of pituitary sst subtypes in male and of sst2A only in females. Thus, fasting can reduce SST sensitivity across tissues and SST input to the pituitary, thereby jointly contributing to enhance GH release. In SST-knockout mice, lack of SST differentially altered sst subtype expression levels in both sexes, supporting an important role for SST in sex-dependent control of GH axis. Evaluation of SST, IGF-I, and glucocorticoid effects on hypothalamic and pituitary cell cultures revealed that these hormones could directly account for alterations in sst2/5 expression in the physiological states examined. Taken together, these results indicate that changes in SST output and sensitivity can contribute critically to precisely define, in a tissue-dependent manner, the sex-specific metabolic regulation of the GH axis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943754      PMCID: PMC3023207          DOI: 10.1152/ajpendo.00514.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  71 in total

Review 1.  Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender.

Authors:  J D Veldhuis
Journal:  Growth Horm IGF Res       Date:  1998-04       Impact factor: 2.372

2.  Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth.

Authors:  M J Low; V Otero-Corchon; A F Parlow; J L Ramirez; U Kumar; Y C Patel; M Rubinstein
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Neuroregulation of growth hormone secretion in domestic animals.

Authors:  C D McMahon; R P Radcliff; K J Lookingland; H A Tucker
Journal:  Domest Anim Endocrinol       Date:  2001-02       Impact factor: 2.290

Review 4.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

5.  Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.

Authors:  A E Rigamonti; N Marazzi; S G Cella; L Cattaneo; E E Müller
Journal:  J Endocrinol       Date:  1998-02       Impact factor: 4.286

6.  Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise.

Authors:  L Wideman; J Y Weltman; J T Patrie; C Y Bowers; N Shah; S Story; J D Veldhuis; A Weltman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

7.  Increased pituitary growth hormone-releasing factor (GRF) receptor messenger ribonucleic acid expression in food-deprived rats.

Authors:  H Sugihara; N Emoto; T Shibasaki; S Minami; I Wakabayashi
Journal:  Brain Res       Date:  1996-12-02       Impact factor: 3.252

8.  Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries.

Authors:  N Kimura; S Tomizawa; K N Arai; N Kimura
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

9.  Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents.

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Mario Duran-Prado; Ana I Pozo-Salas; María M Malagón; F Gracia-Navarro; Rhonda D Kineman; Raul M Luque; Justo P Castaño
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

10.  Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach.

Authors:  Manuel D Gahete; Jose Córdoba-Chacón; Roberto Salvatori; Justo P Castaño; Rhonda D Kineman; Raul M Luque
Journal:  Mol Cell Endocrinol       Date:  2009-12-23       Impact factor: 4.102

View more
  17 in total

1.  Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin, growth hormone (GH)-releasing hormone, and ghrelin in a nonhuman primate (Papio anubis).

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Justo P Castaño; Rhonda D Kineman; Raul M Luque
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

2.  Peripubertal-onset but not adult-onset obesity increases IGF-I and drives development of lean mass, which may lessen the metabolic impairment in adult obesity.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Ana I Pozo-Salas; Antonio Moreno-Herrera; Justo P Castaño; Rhonda D Kineman; Raúl M Luque
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-28       Impact factor: 4.310

3.  Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in female primates and male/female mice.

Authors:  Raúl M Luque; José Córdoba-Chacón; Alejandro Ibáñez-Costa; Iacopo Gesmundo; Cristina Grande; Francisco Gracia-Navarro; Manuel Tena-Sempere; Ezio Ghigo; Manuel D Gahete; Riccarda Granata; Rhonda D Kineman; Justo P Castaño
Journal:  Endocrinology       Date:  2014-01-31       Impact factor: 4.736

4.  Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay.

Authors:  Thomas Günther; Michael Culler; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2016-03-11

5.  Somatostatin is essential for the sexual dimorphism of GH secretion, corticosteroid-binding globulin production, and corticosterone levels in mice.

Authors:  Jessica M Adams; Veronica Otero-Corchon; Geoffrey L Hammond; Johannes D Veldhuis; Nathan Qi; Malcolm J Low
Journal:  Endocrinology       Date:  2014-12-31       Impact factor: 4.736

6.  Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin.

Authors:  José Córdoba-Chacón; Manuel D Gahete; Ana I Pozo-Salas; Antonio J Martínez-Fuentes; Luis de Lecea; Francisco Gracia-Navarro; Rhonda D Kineman; Justo P Castaño; Raul M Luque
Journal:  Endocrinology       Date:  2011-10-04       Impact factor: 4.736

Review 7.  Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Authors:  Raul M Luque; Manuel D Gahete; Jose Cordoba-Chacon; Gwen V Childs; Rhonda D Kineman
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

8.  Hepatic Long Intergenic Noncoding RNAs: High Promoter Conservation and Dynamic, Sex-Dependent Transcriptional Regulation by Growth Hormone.

Authors:  Tisha Melia; Pengying Hao; Feyza Yilmaz; David J Waxman
Journal:  Mol Cell Biol       Date:  2015-10-12       Impact factor: 4.272

9.  Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.

Authors:  Monique Tremblay; Diane Brisson; Daniel Gaudet
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

10.  Peptide receptor targeting in cancer: the somatostatin paradigm.

Authors:  Federica Barbieri; Adriana Bajetto; Alessandra Pattarozzi; Monica Gatti; Roberto Würth; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Pept       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.